Abstract
Background
Cardiovascular disease is the most common cause of death in patients with chronic kidney disease (CKD). Epicardial adipose tissue (EAT) is an independent predictor of cardiovascular disease in the general population, and usually increases in the patients with cardiovascular disease risk. The change of EAT in patients with CKD was still controversial. For further understanding, we conducted a meta-analysis of the relevant literature.
Methods
Eligible studies were searched in PubMed, EMBASE, Web of Science, and Scopus on March 13, 2020. The summarized standard mean difference (SMD) with 95% confidence intervals (CIs) were used to assess the association between EAT (thickness and volume) and CKD. Trial sequential analysis was conducted to estimate whether the evidence of the results is sufficient.
Results
In total, 17 studies with 1961 participants (1205 patients in the CKD group and 756 participants in the control group) were involved. The EAT thickness was significantly increased in the CKD group compared to the control group (SMD = 1.31, 95% CI 0.89–1.73, P < 0.001) in eleven studies. The EAT volume was significantly increased in the CKD group compared to the control group (SMD = 0.77, 95% CI 0.63–0.91, P < 0.001) in six studies. Trial sequential analysis indicated that the available samples were sufficient and confirmed that firm evidence was reached.
Conclusions
Patients with CKD have higher EAT thickness and volume compared to control subjects without CKD.
Similar content being viewed by others
Availability of data and material
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Chen TK, Knicely DH, Grams ME (2019) Chronic kidney disease diagnosis and management: a review. JAMA 322(13):1294–1304
Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, Massy Z, Wanner C, Anders HJ (2017) Chronic kidney disease. Nat Rev Dis Primers 3:17088
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382(9888):260–272
Chiu DY, Green D, Abidin N, Sinha S, Kalra PA (2015) Cardiac imaging in patients with chronic kidney disease. Nat Rev Nephrol 11(4):207–220
Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Marwick TH, Conference P (2019) Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 74(14):1823–1838
Iacobellis G (2015) Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol 11(6):363–371
Xu Y, Cheng X, Hong K, Huang C, Wan L (2012) How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis. Coron Artery Dis 23(4):227–233
Li Y, Liu B, Li Y, Jing X, Deng S, Yan Y, She Q (2019) Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol 18(1):3
Erkan AF, Tanindi A, Kocaman SA, Ugurlu M, Tore HF (2016) Epicardial adipose tissue thickness is an independent predictor of critical and complex coronary artery disease by Gensini and Syntax Scores. Tex Heart Inst J 43(1):29–37
Versteylen MO, Takx RA, Joosen IA, Nelemans PJ, Das M, Crijns HJ, Hofstra L, Leiner T (2012) Epicardial adipose tissue volume as a predictor for coronary artery disease in diabetic, impaired fasting glucose, and non-diabetic patients presenting with chest pain. Eur Heart J Cardiovasc Imaging 13(6):517–523
Sheng YN, Zhao DM, Ma QL, Gao Y (2017) Association between epicardial fat volume and coronary artery calcification in patients with chronic kidney disease. Chin J Cardiol 45(2):121–125
Karatas A, Canakci E, Bektas O, Bayrak T, Bayrak A, Altinbas A, Turkmen E (2018) Relationship of epicardial fat tissue thickness with oxidant biomarkers in chronic kidney disease. Bratisl Lek Listy 119(9):566–571
Ozkurt S, Karavelioǧlu Y, Musmul A (2013) Echocardiographic evaluation of epicardial adipose tissue in non-diabetic, non-hypertensive hemodialysis patients. Ren Fail 35(6):891–895
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535
Iacobellis G, Willens HJ (2009) Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 22(12):1311–1319 (quiz 1417-1318)
Ueno K, Anzai T, Jinzaki M, Yamada M, Jo Y, Maekawa Y, Kawamura A, Yoshikawa T, Tanami Y, Sato K, Kuribayashi S, Ogawa S (2009) Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions. Circ J 73(10):1927–1933
National Kidney F (2015) KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis 66(5):884–930
Wetterslev J, Jakobsen JC, Gluud C (2017) Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol 17(1):39
Tonbul HZ, Turkmen K, Kayikcioglu H, Ozbek O, Kayrak M, Biyik Z (2011) Epicardial adipose tissue and coronary artery calcification in diabetic and nondiabetic end-stage renal disease patients. Ren Fail 33(8):770–775
Turkmen K, Kayikcioglu H, Ozbek O, Solak Y, Kayrak M, Samur C, Anil M, Zeki Tonbul H (2011) The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/calcification syndrome in ESRD patients. Clin J Am Soc Nephrol CJASN 6(8):1920–1925
Turkmen K, Ozbek O, Kayikcioglu H, Kayrak M, Solak Y, Nayman A, Anil M, Babur H, Tonbul HZ (2012) The relationship between epicardial adipose tissue and coronary artery calcification in peritoneal dialysis patients. Cardiorenal Med 2(1):43–51
Erdur MF, Tonbul HZ, Ozbiner H, Ozcicek A, Ozcicek F, Akbas EM, Ozbek O, Hamur H, Turkmen K (2013) The relationship between atherogenic index of plasma and epicardial adipose tissue in hemodialysis and peritoneal dialysis patients. Ren Fail 35(9):1193–1198
Altun B, Tasolar H, Eren N, Binnetoʇlu E, Altun M, Temiz A, Gazi E, Barutcu A, Altunoren O, Colkesen Y, Uysal F (2014) Epicardial adipose tissue thickness in hemodialysis patients. Echocardiography (Mount Kisco, NY) 31(8):941–946
Atakan A, Macunluoglu B, Kaya Y, Ari E, Demir H, Asicioglu E, Kaspar C (2014) Epicardial fat thickness is associated with impaired coronary flow reserve in hemodialysis patients. Hemodial Int 18(1):62–69
Colak H, Kilicarslan B, Tekce H, Tanrisev M, Tugmen C, Aktas G, Kursat S (2015) Relationship between epicardial adipose tissue, inflammation and volume markers in hemodialysis and transplant patients. Ther Apher Dial 19(1):56–62
Nakanishi K, Fukuda S, Tanaka A, Otsuka K, Taguchi H, Yoshikawa J, Shimada K (2016) Epicardial adipose tissue accumulation is associated with renal dysfunction and coronary plaque morphology on multidetector computed tomography. Circ J 80(1):196–201
Abdallah E, El-Shishtawy S, Sherif N, Ali A, El-Bendary O (2017) Assessment of the relationship between serum paraoxonase activity and epicardial adipose tissue in hemodialysis patients. Int Urol Nephrol 49(2):329–335
Aydin E, Altin C, Sakallioglu O, Yilmaz M, Gezmis E, Elif Sade L, Muderrisoglu H (2017) Epicardial adipose tissue thickness and carotid intima-media thickness in hemodialysis patients. Acta Cardiol Sinica 33(3):266–272
Gok Oguz E, Akoglu H, Ulusal Okyay G, Karaveli Gursoy G, Yildirim T, Merhametsiz O, Cimen T, Canbakan B, Yeter E, Ayli MD (2017) Increased serum renalase in peritoneal dialysis patients: Is it related to cardiovascular disease risk? Nefrologia 37(2):189–194
Ozcicek A, Ozcicek F, Yildiz G, Timuroglu A, Demirtas L, Buyuklu M, Kuyrukluyildiz U, Akbas EM, Topal E, Turkmen K (2017) Neutrophil-to-lymphocyte ratio as a possible indicator of epicardial adipose tissue in patients undergoing hemodialysis. Arch Med Sci AMS 13(1):118–123
Ayan H, Akilli R, Kaya B, Paydas S, Kara E, Cureoglu A (2019) Relationship between SCUBE1 levels and echocardiography and electrocardiography findings and epicardial adipose tissue/carotid intima-media thickness in patients receiving renal replacement therapy. Exp Clin Transplant 17:181–187
Yilmaz Z, İnce H, Aydin E, Yildirim Y, Yilmaz Aydin F, Yüksel E, Karabulut A, Dursun L, Kadiroğlu AK, Yilmaz ME (2020) Relationship between epicardial adipose tissue and body composition as determined by multi-frequency bioelectrical impedance analysis in patients with stage 5 chronic kidney disease. Med Sci Monit 26:e920233
Silberberg JS, Barre PE, Prichard SS, Sniderman AD (1989) Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36(2):286–290
Tonelli M, Karumanchi SA, Thadhani R (2016) Epidemiology and mechanisms of uremia-related cardiovascular disease. Circulation 133(5):518–536
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382(9889):339–352
Aoqui C, Cuppari L, Kamimura MA, Canziani ME (2013) Increased visceral adiposity is associated with coronary artery calcification in male patients with chronic kidney disease. Eur J Clin Nutr 67(6):610–614
Kamimura MA, Carrero JJ, Canziani ME, Watanabe R, Lemos MM, Cuppari L (2013) Visceral obesity assessed by computed tomography predicts cardiovascular events in chronic kidney disease patients. Nutr Metab Cardiovasc Dis NMCD 23(9):891–897
Cordeiro AC, Qureshi AR, Lindholm B, Amparo FC, Tito-Paladino-Filho A, Perini M, Lourenco FS, Pinto IM, Amodeo C, Carrero JJ (2013) Visceral fat and coronary artery calcification in patients with chronic kidney disease. Nephrol Dial Transplant 28(Suppl 4):iv152–159
Oikawa M, Owada T, Yamauchi H, Misaka T, Machii H, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y (2015) Epicardial adipose tissue reflects the presence of coronary artery disease: comparison with abdominal visceral adipose tissue. Biomed Res Int 2015:483982
Lin HH, Lee JK, Yang CY, Lien YC, Huang JW, Wu CK (2013) Accumulation of epicardial fat rather than visceral fat is an independent risk factor for left ventricular diastolic dysfunction in patients undergoing peritoneal dialysis. Cardiovasc Diabetol 12:127
Karastergiou K, Evans I, Ogston N, Miheisi N, Nair D, Kaski JC, Jahangiri M, Mohamed-Ali V (2010) Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells. Arterioscler Thromb Vasc Biol 30(7):1340–1346
Gaborit B, Sengenes C, Ancel P, Jacquier A, Dutour A (2017) Role of epicardial adipose tissue in health and disease: a matter of fat? Compr Physiol 7(3):1051–1082
Turan MN, Gungor O, Asci G, Kircelli F, Acar T, Yaprak M, Ceylan N, Demirci MS, Bayraktaroglu S, Toz H, Ozkahya M, Ok E (2013) Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients. Atherosclerosis 226(1):129–133
D'Marco LG, Bellasi A, Kim S, Chen Z, Block GA, Raggi P (2013) Epicardial adipose tissue predicts mortality in incident hemodialysis patients: a substudy of the Renagel in New Dialysis trial. Nephrol Dial Transplant 28(10):2586–2595
Cordeiro AC, Amparo FC, Oliveira MA, Amodeo C, Smanio P, Pinto IM, Lindholm B, Stenvinkel P, Carrero JJ (2015) Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 3–5 chronic kidney disease. J Intern Med 278(1):77–87
Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B (2005) Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293(14):1737–1745
Salazar J, Luzardo E, Mejias JC, Rojas J, Ferreira A, Rivas-Rios JR, Bermudez V (2016) Epicardial fat: physiological, pathological, and therapeutic implications. Cardiol Res Pract 2016:1291537
Kurella M, Lo JC, Chertow GM (2005) Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol JASN 16(7):2134–2140
Banerjee D, Recio-Mayoral A, Chitalia N, Kaski JC (2011) Insulin resistance, inflammation, and vascular disease in nondiabetic predialysis chronic kidney disease patients. Clin Cardiol 34(6):360–365
Rhee CM, Ahmadi SF, Kalantar-Zadeh K (2016) The dual roles of obesity in chronic kidney disease: a review of the current literature. Curr Opin Nephrol Hypertens 25(3):208–216
Ulusal Okyay G, Okyay K, Polattas Solak E, Sahinarslan A, Pasaoglu O, Ayerden Ebinc F, Pasaoglu H, Boztepe Derici U, Sindel S, Arinsoy T (2015) Echocardiographic epicardial adipose tissue measurements provide information about cardiovascular risk in hemodialysis patients. Hemodial Int 19(3):452–462
Funding
None.
Author information
Authors and Affiliations
Contributions
GS designed the study, collected the data and drafted the manuscript. WQ collected the data and analyzed the data. KL collected the data and analyzed the data. XY analyzed the data and drafted the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethical statement
The authors have no ethical conflicts to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Song, G., Qiao, W., Liu, K. et al. Epicardial adipose tissue in patients with chronic kidney disease: a meta-analysis study and trial sequential analysis. Int Urol Nephrol 52, 2345–2355 (2020). https://doi.org/10.1007/s11255-020-02575-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-020-02575-y